160 related articles for article (PubMed ID: 21521776)
1. Genomic profiles specific to patient ethnicity in lung adenocarcinoma.
Broët P; Dalmasso C; Tan EH; Alifano M; Zhang S; Wu J; Lee MH; Régnard JF; Lim D; Koong HN; Agasthian T; Miller LD; Lim E; Camilleri-Broët S; Tan P
Clin Cancer Res; 2011 Jun; 17(11):3542-50. PubMed ID: 21521776
[TBL] [Abstract][Full Text] [Related]
2. Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors.
Bjaanæs MM; Nilsen G; Halvorsen AR; Russnes HG; Solberg S; Jørgensen L; Brustugun OT; Lingjærde OC; Helland Å
BMC Cancer; 2021 Oct; 21(1):1089. PubMed ID: 34625038
[TBL] [Abstract][Full Text] [Related]
3. Genomic and transcriptional alterations in lung adenocarcinoma in relation to EGFR and KRAS mutation status.
Planck M; Edlund K; Botling J; Micke P; Isaksson S; Staaf J
PLoS One; 2013; 8(10):e78614. PubMed ID: 24205279
[TBL] [Abstract][Full Text] [Related]
4. Putative effectors for prognosis in lung adenocarcinoma are ethnic and gender specific.
Woolston A; Sintupisut N; Lu TP; Lai LC; Tsai MH; Chuang EY; Yeang CH
Oncotarget; 2015 Aug; 6(23):19483-99. PubMed ID: 26160836
[TBL] [Abstract][Full Text] [Related]
5. Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations.
Yuan S; Yu SL; Chen HY; Hsu YC; Su KY; Chen HW; Chen CY; Yu CJ; Shih JY; Chang YL; Cheng CL; Hsu CP; Hsia JY; Lin CY; Wu G; Liu CH; Wang CD; Yang KC; Chen YW; Lai YL; Hsu CC; Lin TC; Yang TY; Chen KC; Hsu KH; Chen JJ; Chang GC; Li KC; Yang PC
J Clin Oncol; 2011 Sep; 29(25):3435-42. PubMed ID: 21810691
[TBL] [Abstract][Full Text] [Related]
6. Intertumor heterogeneity of non-small-cell lung carcinomas revealed by multiplexed mutation profiling and integrative genomics.
Tan DS; Camilleri-Broët S; Tan EH; Alifano M; Lim WT; Bobbio A; Zhang S; Ng QS; Ang MK; Iyer NG; Takano A; Lim KH; Régnard JF; Tan P; Broët P
Int J Cancer; 2014 Sep; 135(5):1092-100. PubMed ID: 24482041
[TBL] [Abstract][Full Text] [Related]
7. Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium.
Steuer CE; Behera M; Berry L; Kim S; Rossi M; Sica G; Owonikoko TK; Johnson BE; Kris MG; Bunn PA; Khuri FR; Garon EB; Ramalingam SS
Cancer; 2016 Mar; 122(5):766-72. PubMed ID: 26695526
[TBL] [Abstract][Full Text] [Related]
8. Impact of Concurrent Genomic Alterations Detected by Comprehensive Genomic Sequencing on Clinical Outcomes in East-Asian Patients with EGFR-Mutated Lung Adenocarcinoma.
Sato S; Nagahashi M; Koike T; Ichikawa H; Shimada Y; Watanabe S; Kikuchi T; Takada K; Nakanishi R; Oki E; Okamoto T; Akazawa K; Lyle S; Ling Y; Takabe K; Okuda S; Wakai T; Tsuchida M
Sci Rep; 2018 Jan; 8(1):1005. PubMed ID: 29343775
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the clinical relevance of 17q25.3 copy number and three-dimensional telomere organization in non-small lung cancer patients.
Sunpaweravong P; Thu KL; Lam WL; Mai S
J Cancer Res Clin Oncol; 2016 Apr; 142(4):749-56. PubMed ID: 26621152
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas.
Seo AN; Yang JM; Kim H; Jheon S; Kim K; Lee CT; Jin Y; Yun S; Chung JH; Paik JH
Br J Cancer; 2014 May; 110(11):2688-99. PubMed ID: 24809777
[TBL] [Abstract][Full Text] [Related]
11. Gene expression and copy number profiling suggests the importance of allelic imbalance in 19p in asbestos-associated lung cancer.
Wikman H; Ruosaari S; Nymark P; Sarhadi VK; Saharinen J; Vanhala E; Karjalainen A; Hollmén J; Knuutila S; Anttila S
Oncogene; 2007 Jul; 26(32):4730-7. PubMed ID: 17297452
[TBL] [Abstract][Full Text] [Related]
12. Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma.
Wang X; Li X; Cheng Y; Sun X; Sun X; Self S; Kooperberg C; Dai JY
Hum Genomics; 2015 Sep; 9(1):22. PubMed ID: 26374103
[TBL] [Abstract][Full Text] [Related]
13. Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability.
Thu KL; Vucic EA; Chari R; Zhang W; Lockwood WW; English JC; Fu R; Wang P; Feng Z; MacAulay CE; Gazdar AF; Lam S; Lam WL
PLoS One; 2012; 7(3):e33003. PubMed ID: 22412972
[TBL] [Abstract][Full Text] [Related]
14. Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma.
Naka T; Hatanaka Y; Marukawa K; Okada H; Hatanaka KC; Sakakibara-Konishi J; Oizumi S; Hida Y; Kaga K; Mitsuhashi T; Matsuno Y
Diagn Pathol; 2016 Apr; 11():38. PubMed ID: 27091358
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of epidermal growth factor receptor gene status in lung adenocarcinoma.
Li C; Sun Y; Fang Z; Han X; Fang R; Zhang Y; Pan Y; Zhang W; Ren Y; Ji H; Chen H
J Thorac Oncol; 2011 Jun; 6(6):1016-21. PubMed ID: 21532505
[TBL] [Abstract][Full Text] [Related]
16. The relationship between EGFR gain and VHL loss in lung adenocarcinoma and poor patient survival.
Zhao Y; Li Y; Wang S; Lu H; Chen J; Zhang Z; Jin Y; Zhu ZZ
Int J Clin Oncol; 2011 Dec; 16(6):679-85. PubMed ID: 21556796
[TBL] [Abstract][Full Text] [Related]
17. Gene copy number aberrations are associated with survival in histologic subgroups of non-small cell lung cancer.
Micke P; Edlund K; Holmberg L; Kultima HG; Mansouri L; Ekman S; Bergqvist M; Scheibenflug L; Lamberg K; Myrdal G; Berglund A; Andersson A; Lambe M; Nyberg F; Thomas A; Isaksson A; Botling J
J Thorac Oncol; 2011 Nov; 6(11):1833-40. PubMed ID: 22011649
[TBL] [Abstract][Full Text] [Related]
18. [Correlation between EGFR gene mutation and high copy number and their association with the clinicopathological features in Chinese patients with non-small cell lung cancer].
Li Z; Zhang LJ; Wang WP; Guo K; Shao JY; Rong TH
Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):666-70. PubMed ID: 22340046
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Prevalence and Types of Mutations in Lung Cancers Among Black and White Populations.
Campbell JD; Lathan C; Sholl L; Ducar M; Vega M; Sunkavalli A; Lin L; Hanna M; Schubert L; Thorner A; Faris N; Williams DR; Osarogiagbon RU; van Hummelen P; Meyerson M; MacConaill L
JAMA Oncol; 2017 Jun; 3(6):801-809. PubMed ID: 28114446
[TBL] [Abstract][Full Text] [Related]
20. Genomic and transcriptional alterations in lung adenocarcinoma in relation to smoking history.
Karlsson A; Ringnér M; Lauss M; Botling J; Micke P; Planck M; Staaf J
Clin Cancer Res; 2014 Sep; 20(18):4912-24. PubMed ID: 25037737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]